• Skip to main content

Plain Language Summaries

Standalone, citable summaries published in the Future Science Group journals written to be understood by a lay audience

  • How To Publish
  • How to Write Plain Language Summaries
  • Frequently Asked Questions
  • Publications
    • Animated Videos
    • Bladder, Kidney and Genitals
    • Brain and Nerves
    • Cancer
    • Diabetes and Metabolic Hormones
    • Eyes and Vision
    • Heart and Circulation
    • Infections
    • Inflammatory and Immune-related disorders
    • Mental Health
    • Muscle and Bone
    • Rare Diseases
    • Skin
    • Vaccines
  • Advisory Panel
  • Supporters
  • Blog
  • About Us
  • Contact Us

Diabetes and Metabolic Hormones

Sep 15 2022

Osilodrostat for the treatment of Cushing’s disease: a plain language summary of the LINC 4 study

A new plain language summary of publication from Future Rare Diseases discusses the results of the LINC 4 study, which looked at how effective osilodrostat was in patients with Cushing’s disease and what the side effects were.

Read the summary here.

The original article on which this summary is based is called ‘Randomized Trial of Osilodrostat for the Treatment of Cushing Disease’ and was originally published in The Journal of Clinical Endocrinology & Metabolism. The original article can be read here.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Diabetes and Metabolic Hormones · Tagged: Cushing's disease, osilodrostat

May 20 2022

Plain language summary of the MPOWERED trial comparing the effectiveness, safety, and patient experiences’ of monthly injections and oral medication used to treat acromegaly

The MPOWERED study looked oral octreotide as a treatment for patients with acromegaly. This plain language summary can help people understand the findings from this study.

Read the full article here.

Click here to read the original article on which this summary is based.

  • Share on Twitter Share on Twitter
  • Share on Facebook Share on Facebook
  • Share on LinkedIn Share on LinkedIn

Written by Joanne Walker · Categorized: Diabetes and Metabolic Hormones, Rare Diseases · Tagged: acromegaly, MPOWERED, oral octreotide, patient-reported outcomes, somatostatin analog

Copyright © 2023 · Plain Language Summaries · Terms and Conditions · Privacy Policy ·